Boston Scientific (HAM:BSX) Cyclically Adjusted PB Ratio: (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:BSX Boston Scientific Corp HAM:BSX
74 GF Score
Price €39.91
GF Value €92.30
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Boston Scientific  (HAM:BSX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Boston Scientific Cyclically Adjusted PB Ratio Related Terms


Boston Scientific Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Cyclically Adjusted PB Ratio Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.77 5.58 6.28 8.73 8.36

Boston Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.87 8.73 8.36 5.27 0.00

HAM:BSX vs EW, DXCM, GEHC: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted PB Ratio falls into.


HAM:BSX
74GF Score
Boston Scientific Corp HAM:BSX
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Boston Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Boston Scientific's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=14.958/333.9520*333.9520
=14.958

Current CPI (Jun. 2026) = 333.9520.

Boston Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201609 4.242 241.428 5.868
201612 4.686 241.432 6.482
201703 4.817 243.801 6.598
201706 4.699 244.955 6.406
201709 4.638 246.819 6.275
201712 4.313 246.524 5.843
201803 4.132 249.554 5.529
201806 4.799 251.989 6.360
201809 5.134 252.439 6.792
201812 5.539 251.233 7.363
201903 5.875 254.202 7.718
201906 5.994 256.143 7.815
201909 6.318 256.759 8.217
201912 8.953 256.974 11.635
202003 8.928 258.115 11.551
202006 9.703 257.797 12.569
202009 9.228 260.280 11.840
202012 8.894 260.474 11.403
202103 9.295 264.877 11.719
202106 9.307 271.696 11.440
202109 9.821 274.310 11.956
202112 10.320 278.802 12.361
202203 10.630 287.504 12.347
202206 11.414 296.311 12.864
202209 12.441 296.808 13.998
202212 11.574 296.797 13.023
202303 11.598 301.836 12.832
202306 11.501 305.109 12.588
202309 12.080 307.789 13.107
202312 12.063 306.746 13.133
202403 12.470 312.332 13.333
202406 12.865 314.175 13.675
202409 12.663 315.301 13.412
202412 14.099 315.605 14.919
202503 13.890 319.799 14.505
202506 13.130 322.561 13.594
202509 13.447 324.800 13.826
202512 13.954 324.054 14.380
202603 15.052 330.213 15.222
202606 14.958 333.952 14.958

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Boston Scientific (HAM:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of €39.91 is trading 56.8% below its estimated GF Value™ of €92.30. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for HAM:BSX:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €92.30 vs. price of €39.91 (56.8% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the HAM:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
74GF Score

Get the complete analysis for HAM:BSX

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.91
Price
€92.30
GF Value